The estimated Net Worth of Louis S Schmukler is at least $14.3 Million dollars as of 10 May 2021. Mr. Schmukler owns over 15,000 units of Bristol-Myers Squibb Co stock worth over $1,552,742 and over the last 13 years he sold BMY stock worth over $8,637,195. In addition, he makes $4,127,370 as Executive Vice President and President - Global Product Development and Supply at Bristol-Myers Squibb Co.
Louis has made over 25 trades of the Bristol-Myers Squibb Co stock since 2012, according to the Form 4 filled with the SEC. Most recently he sold 15,000 units of BMY stock worth $978,750 on 10 May 2021.
The largest trade he's ever made was exercising 34,681 units of Bristol-Myers Squibb Co stock on 10 March 2018 worth over $1,685,150. On average, Louis trades about 13,500 units every 105 days since 2011. As of 10 May 2021 he still owns at least 31,956 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Mr. Schmukler stock trades at the bottom of the page.
Louis S. Schmukler serves as Executive Vice President, President - Global Product Development and Supply of the Company. From 2011 to 2017 – President, Global Product Development and Supply 2017 to 2019 – Senior Vice President and President, Global Product Development and Supply 2019 to present – Executive Vice President and President, Global Product Development and Supply
As the Executive Vice President and President - Global Product Development and Supply of Bristol-Myers Squibb Co, the total compensation of Louis Schmukler at Bristol-Myers Squibb Co is $4,127,370. There are 6 executives at Bristol-Myers Squibb Co getting paid more, with Giovanni Caforio having the highest compensation of $18,767,300.
Louis Schmukler is 64, he's been the Executive Vice President and President - Global Product Development and Supply of Bristol-Myers Squibb Co since 2019. There are 4 older and 32 younger executives at Bristol-Myers Squibb Co. The oldest executive at Bristol-Myers Squibb Co. is Vicki Sato, 71, who is the Lead Independent Director.
Louis's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, 430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, 10016.
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius, and Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include: